Remember that optimizing cardiovascular risk factorsincluding blood pressure, cholesterol, and smoking cessationprotects both heart and brain health in the long term
Sleep-breathing device manufacturer ResMed is actively positioning the global surge in GLP-1 weight loss medications, such as Ozempic and Zepbound, as a significant sales opportunity rather than a competitive threat
Zumindest die absolute Risikoreduktion ist dann deutlich geringer als bei manifester Herz-Kreislauf-Erkrankung (42)
"The policy changes around the anti-obesity drug class for the Medicaid program, I think, will be positive policy changes, so that we can focus spending on anti-obesity on those that are likely to see the greatest improvement in health outcomes," said Dominick Pallone, executive director of the Michigan Association of Health Plans
adems, podr pagar en efectivo o en algn OXXO
The LLY Vs Novo Nordisk A/S Race Lilly, the maker of Zepbound (tirzepatide) and orforglipron, is strengthening its obesity pipeline with retatrutide
